16 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
manufacturing facilities. We currently depend on and expect to continue to depend on third-party CMOs for all of our requirements of raw materials, drug … agreements. Furthermore, while the raw materials for our product candidates are sourced from multiple suppliers, in some cases, the drug product
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
and clinical trials under the guidance of members of our organization. We do not have long-term supply agreements. Furthermore, while the raw materials … of suppliers for raw materials that we use to manufacture our drugs and there may be a need to assess alternate suppliers to prevent a possible disruption
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
the raw materials for our product candidates are sourced from multiple suppliers, in some cases, the drug product is sourced from a single-source … . There are a limited number of suppliers for raw materials that we use to manufacture our drugs and there may be a need to assess alternate suppliers to prevent
S-1
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
organization. We do not have long-term supply agreements. Furthermore, while the raw materials for our product candidates are sourced from multiple … on these third parties for any clinical trials that we undertake. There are a limited number of suppliers for raw materials that we use to manufacture
S-1
EX-10.14
5860w6guv ngt1
25 Aug 23
IPO registration
5:03pm
DRS/A
f8sq4
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
itv2ag6wv7zo52n5
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
8ukr2 rd0pfqf
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
sxh17kucs
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
i1ftucx
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
s5jaex4 jkr
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
47fy5n5g
23 Dec 21
Draft registration statement (amended)
12:00am
DRSLTR
xwiacvql8tfwg5x11xu
22 Dec 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
c6ldxbv1tqrcx51z2m57
6 Dec 21
Letter from SEC
12:00am
DRS
5mm02v4
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next